scholarly journals A CASE STUDY ON CLINICAL PHARMACIST INTERVENTIONS IN THE MANAGEMENT OF DIABETES COMPLICATED CORONARY ARTERY DISEASE IN HEALTH-CARE PRACTICE

Author(s):  
BHARATH KUMAR A ◽  
UMASHANKAR MS

Objective: The objective of the study was to assess the clinical pharmacist interventions in the management of diabetes complicated coronary artery disease. Methods: In the present study, a case history of a 55-year-old female was suffering from diabetes with coronary artery disease was taken. The case was collected from the cardiology outpatient department in a tertiary care hospital. The case was analyzed from 1 to 3 months. The initial visit to the end of final visit her laboratory parameters was examined at the laboratory. Results: The test report of electrocardiogram revealed sinus rhythm. The patient was advised for an echocardiogram which confirmed coronary artery disease. The patient was subjected to a coronary angiogram, which revealed the presence of double-vessel disease. Her ankle-brachial index study test revealed peripheral artery disease. The patient was diagnosed with coronary artery disease, and she was prescribed with regular medications. The patient was monitored for 1-week duration and prescribed with coronary artery disease medications to normalize the condition. The patient was improved with the treatment and advised for regular follow-ups. Conclusion: The study concludes that there was an imperative need for regular health screening by the physician associated clinical pharmacist care services with an effective treatment modality that can reduce the coronary artery disease incidences in this patient.

2021 ◽  
Vol 15 (9) ◽  
pp. 2757-2762
Author(s):  
Vinesh Kumar ◽  
Fawad Ali Siddiqui ◽  
Kiran Irfan ◽  
Muhammad Adeel Qamar ◽  
Ghulam Jaffar Shah ◽  
...  

Introduction: Higher levels of troponins >10 folds of upper normal limits (UNL) are considered as high-risk patients on coronary angiography sufferers having high levels of troponin-I (>10 folds upper limit normal level) had extra three-vessel coronary artery disease involvement. Objectives: To determine the frequency of degree of cardiovascular disease with Troponin-I level >10 folds ULN in NSTEMI patients at tertiary care hospital. Methodology: It is a cross-sectional study comprising of a total 800 patients recruited from the Department of Cardiology, National Institute of Coronary Disease, Karachi Pakistan based on Exclusion/Inclusion criteria. Results: There are 678 male as well as 122 female patients. The mean troponin-I level was 15.00±6.82 ng/ml. Single vessel disease found in 25.25% cases, two vessel diseases were observed in 37.75% cases, and three vessel diseases were observed in 20% cases. 83% were found with extent of CAD findings on angiography. There have been 678 male and also 122 female patients. The mean troponin-I level was 15.00±6.82 ng/ml. Single vessel disease found in 25.25% cases, two vessel diseases were observed in 37.75% cases, and three vessel diseases were observed in 20% cases. 83% were found with extent of CAD findings on angiography. Conclusion: The higher troponin level found significantly associated with extent of CAD and three vessel disease. To understand the cardiovascular troponin condition of the sufferer as soon as feasible is crucial. Keywords: Extent of Coronary Artery Disease, NSTEMI, Troponin-I Level >10 Folds ULN


CJEM ◽  
2006 ◽  
Vol 8 (03) ◽  
pp. 164-169 ◽  
Author(s):  
Robert Steele ◽  
Timothy McNaughton ◽  
Melissa McConahy ◽  
John Lam

ABSTRACT Introduction: It is often believed that chest pain relieved by nitroglycerin is indicative of coronary artery disease origin. Objective: To determine if relief of chest pain with nitroglycerin can be used as a diagnostic test to help differentiate cardiac chest pain and non-cardiac chest pain. Design: Prospective observational cohort study with a 4-week follow-up of patients enrolled. Setting: Academic tertiary care hospital, with 60 000 visits/year. Inclusion criteria: Adult patients presenting to the emergency department with active chest pain who received nitroglycerin and were admitted for chest pain. Exclusion criteria: Patients with acute myocardial infarction diagnosed after obtaining an ECG, patients whose chest pain could not be quantified, those for whom no cardiac work-up was done, or those who received emergent cardiac catheterization. Results: 270 patients were enrolled. Nitroglycerin relieved chest pain in 66% of the subjects. The diagnostic sensitivity of nitroglycerin to determine cardiac chest pain was 72% (64%–80%), and the specificity was 37% (34%–41%). The positive likelihood ratio for having coronary artery disease if nitroglycerin relieved chest pain was 1.1 (0.96–1.34). Telephone follow-up at 4 weeks was performed, with a 95% follow-up rate. Conclusions: Relief of chest pain with nitroglycerin is not a reliable diagnostic test and does not distinguish between cardiac and non-cardiac chest pain.


2014 ◽  
Vol 66 ◽  
pp. S115
Author(s):  
Y. Varma ◽  
P. Singh ◽  
R.S. Meena ◽  
B.S. Yadav ◽  
R. Gupta ◽  
...  

2021 ◽  
Vol 40 (1) ◽  
Author(s):  
Taslima Khatun ◽  
Dilara Maqbool ◽  
Ferdous Ara ◽  
Manika Rani Sarker ◽  
Kazi Selim Anwar ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2021 ◽  
Vol 15 (6) ◽  
pp. 1937-1940
Author(s):  
Sharafuddin . ◽  
Javed Khurshed S. ◽  
M. Hashim Kalwar ◽  
M. Hassan Butt ◽  
Sarfraz Hussain Sahito ◽  
...  

Objective: To determine frequency of glycemic control in patients with coronary artery disease (CAD) visiting to National Institute of Cardiovascular Diseases, Karachi. Study Design: Descriptive Cross-Sectional study Place and Duration: This study was conducted at Department of Cardiology, National Institute of Cardiovascular Diseases, Karachi, Pakistan for six months duration from 12th October 2019 to 11th April 2020. Methodology: One hundred and ten patients of both gender with coronary artery disease were enrolled in this study. Informed consent was taken after explaining the procedure, risks and benefits of the study. In our study, all the included patients were given the emergency treatment and their blood samples were sent to laboratory to assess the outcome variable i.e. glycemic control. All the data was analyzed by SPSS 24.0. Results: Mean ± SD of age was 62.5±8.4 years. Out of 110 patients, 65 (59.1%) were male while 45 (40.9%) were female. Obesity was found in 41 (37.3%) patients. Glycemic control was noted in 20 (18.2%) patients. Conclusion: It is to be concluded that less glycemic control was noted among coronary artery disease (CAD) patients with increasing prevalence of diabetes. Indicators of quality care (HbA1c & other complications) should be assessed regularly for better diabetes management. Keywords: Glycemic Control, Coronary Artery Disease, Type 2 Diabetes, Risk Factors


Sign in / Sign up

Export Citation Format

Share Document